Top compounds associated with response to TLCD2


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K09587429 CTRPv2 pan-cancer AAC -0.082 0.07
mRNA sitagliptin CTRPv2 pan-cancer AAC -0.15 0.07
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.06 0.07
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.07 0.07
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.07
mRNA NSC95397 CTRPv2 pan-cancer AAC -0.065 0.08
mRNA myriocin CTRPv2 pan-cancer AAC -0.15 0.08
mRNA temsirolimus CTRPv2 pan-cancer AAC -0.095 0.08
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.069 0.08
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.07 0.08
Download CSV